CME Says It's About to Win 14-Year-Old Eurex Antitrust Lawsuit
- Eurex accuses CME of unfairly blocking its U.S. venture
- CME says judge reached preliminary decision to dismiss case
Photographer: Ralph Orlowski/Bloomberg
This article is for subscribers only.
CME Group Inc. says it’s poised to win a 14-year-old court case that alleges its anti-competitive behavior blocked a huge German exchange from getting a foothold in the U.S.
The judge, CME disclosed in its latest quarterly report, told litigants on April 27 that he “reached a preliminary decision” granting CME’s motion for summary judgment of the antitrust claim. The court “is expected to issue a written decision finalizing that decision and dismissing the entire case,” CME said. Court records show U.S. District Judge Thomas Durkin decided the trial will no longer begin on June 4.